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High mobility group box-1 (HMGB-1) is a DNA-binding protein secreted by activated monocytes and has been identiﬁed as a
key late mediator of endotoxic shock. We investigated the regulation of HMGB-1 in human peripheral blood mononuclear cells
(PBMCs) following stimulation with the staphylococcal superantigen, toxic shock syndrome toxin-1 (TSST-1), and found that
TSST-1, like LPS, induced the secretion of HMGB-1 from human PBMC. However, unlike monocyte-driven sepsis caused by
endotoxin, translocation and secretion of HMGB-1 mediated by TSST-1 was dependent on the presence of both activated T cells
and monocytes. Furthermore, we show that nuclear HMGB-1 is released from TSST-1 stimulated T cells. This ﬁnding presents a
basis for investigating the potential of targeting HMGB-1 for the treatment of toxic shock syndrome, and provides further insight
on the role of HMGB-1 in the cross-talk between activated monocytes and T cells.
Copyright © 2008 S. Kalyan and A. W. Chow. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
High mobility group box-1 (HMGB-1) protein is a 30kDa
nonhistone nuclear DNA binding protein that is shown to
have an extracellular role in inﬂammation, cell diﬀerentia-
tion, adherence, and motility [1–3]. Extracellular HMGB-
1 was initially identiﬁed as amphoterin, a heparin-binding
protein promoting neurite outgrowth in the perinatal rat
brain [4]. HMGB-1 is now regarded as an endogenous dan-
gersignalthatispassivelyreleasedbynecroticcellsoractively
secreted by stimulated cells [5]. Wang et al. discovered that
this pivotal protein was a late mediator of endotoxin shock
[6, 7]. Activated macrophages and monocytes secrete this
inﬂammatory molecule by a process requiring acetylation
of the protein, which permits its translocation from the
nucleus to secretory lysosomes [8]. Unlike TNFα and IFNγ
that appear within the ﬁrst 4–6 hours post-LPS treatment
in mice, HMGB-1 serum levels rise between 16 and 32
hours after LPS administration. Furthermore, neutralizing
antibodies directed at HMGB-1 rescued mice from lethal
endotoxemia even when administered 24 hours after sepsis
initiation [7, 9]. For these reasons, HMGB-1 is viewed as
an attractive therapeutic target for various inﬂammatory
disorders including endotoxic shock [10].
Toxicshocksyndrometoxin-1(TSST-1)isasuperantigen
(sAg) secreted by some strains of S. aureus, and this sAg was
subsequently identiﬁed as the major causative agent of toxic
shock syndrome [11]. In contrast to LPS-induced sepsis,
which is primarily mediated by stimulated monocytes, toxic
shock syndrome induced by sAg’s requires the cross-linking
of Vβ-speciﬁc regions of the αβ T cellreceptor(TCR)toclass
II major histocompatibility complex (MHC II) molecules on
antigen presenting cells (APCs) [12]. In addition to massive
T cell proliferation, this trimolecular interaction leads to the
uncontrolled release of various proinﬂammatory cytokines
[13], which are pivotal to the pathogenesis of TSS. In the
presentstudy,wesoughttodeterminewhetherHMGB-1also
plays a central role in TSST-1-induced hyperinﬂammatory
responses. We found that TSST-1 mediates the translocation
and subsequent secretion of intracellular HMGB-1 from
resting human PBMC. Unlike previous studies that found
that monocytes, but not T cells, released HMGB-1 upon2 Mediators of Inﬂammation
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Figure 1: Secretion of membrane-associated HMGB-1 in the extracellular milieu following TSST-1 treatment. Extracellular expression of
HMGB-1 on adherent PBMC in complete growth medium (a) or after TSST-1 treatment. (b) Anti-HMGB-1: green ﬂuorescence (Alexa488);
nucleus: blue (Hoechst 3342 nuclear dye); anti-CD3: red(Alexa594). Close-upviews fromrepresentative ﬁelds are depicted in the left panels.
(c) Flow cytometry analysis of surface-expressed HMGB-1 in PBMC 24 hours following TSST-1 stimulation. Left panel, resting or PBMC
treated; right panel, 24 hours after TSST-1 stimulation. Surface HMGB-1 expression signiﬁcantly decreased after TSST-1 stimulation (12.0%
versus4.3%inthedonorshown;7.3±3.69%priortostimulationversus3.3±1.32%post-TSST-1treatmentfrom4diﬀerentdonors;P<. 05,
paired Student’s t-test).
stimulationwitheitherLPSorTNFα[6,7,14],wefoundthat
the loss and subsequent secretion of intracellular HMGB-
1 induced by TSST-1 was dependent on the cooperative
interactionofbothTcellsandmonocytes,andbothcelltypes
mobilized HMGB-1 upon TSST-1 treatment.
2. MATERIALS AND METHODS
2.1. Toxinpuriﬁcation
RecombinantTSST-1waspuriﬁedfromculturesupernatants
of S. aureus strain RN4220 previously transformed to carry
the tst gene, using both preparative isoelectric focusing and
chromatofocusing [15]. Toxin purity was assessed by silver
staining after sodium dodecyl sulfate-polyacrylamide gel
electrophoresis on 14% acrylamide gels, and LPS activity
was undetectable by the Limulus amoebocyte lysate gelation
(sensitivity limit, 10pg/mL).
2.2. Preparationofcellsandcultureconditions
Fresh human PBMCs from healthy donors were obtained
by Ficoll-Paque PLUS (Amersham Biosciences Corp., Piscat-
away, NJ, USA) density centrifugation, and cultured in 96-
wellU-bottomplatesat1.5×106 cells/mLincompleteculture
medium consisting of RPMI 1640 (StemCell TechnologiesS. Kalyan and A. W. Chow 3
Inc., Vancouver, BC, Canada), 10% heat-inactivated fetal
bovine serum (HyClone Laboratories Inc., Logan, Utah,
USA), 2mM L-glutamine (StemCell), 25mM Hepes buﬀer
(StemCell), and 2ug/mL of polymyxin B sulphate (Sigma-
Aldrich Corp., St. Louis, Mo, USA). For analysis of secreted
HMGB-1 in cell culture supernatants, PBMCs were plated
in 24-well ﬂat-bottom plates in Opti-MEM I reduced serum
medium (Gibco). THP-1 cells (human monocytic cell line)
wereobtainedfromATCCandkeptinrecommendedgrowth
media until use, at which time the cells were plated at a
concentration of 1.5 × 106 cells in Opti-Mem I medium.
T cell depletion of human PBMC was performed using a
column-free method of magnetic bead separation (EasyCep
from StemCell Technologies) by positive selection of T
cells using an anti-CD3 conjugated antibody according to
manufacturer’sdirections.Thisprocedureleftthemonocytes
negatively selected for and untouched for the purpose of
further experimental investigations.
2.3. TreatmentofPBMCwithTSST-1orLPS
Puriﬁed PBMCs were plated in either 24-well or 96-well
culture plates overnight at 37◦Ci n5 %C O 2 prior to
stimulation with 1nM TSST-1 or 500ng/mL LPS (Sigma),
wherenoted.Culturesupernatantswerecollectedat24hours
post-TSST-1 treatment, microcentrifuged at 800xg for 5
minutes, and frozen at –70◦C until protein analysis.
2.4. DetectionofHMGB-1byﬂuorescentmicroscopy
PBMCs were ﬁrst surface-stained for expression of CD3 with
mouse antihuman CD3 IgG (Pharmingen BD Biosciences,
Mississauga, ON, Canada) followed by antimouse IgG
antibody conjugated to Alexa594 (Molecular Probes); cells
were subsequently ﬁxed using Cytoﬁx buﬀer (Pharmingen).
For the intracellular detection of HMGB-1, cells were
permeabilized with Cytoperm (Pharmingen) and incubated
for 30 minutes (4◦C) with rabbit polyclonal anti-HMGB-1
antibodies(OrbigenBioCarta,SanDiego,Calif,USA)diluted
in blocking buﬀer (phosphate buﬀered saline, 3% FBS)
followed by a secondary antibody with Alexa488-conjugated
goat antirabbit IgG. The anti-HMGB-1 antibodies were
raised against the peptide sequence corresponding to amino
acids 166–181 that were previously shown to be speciﬁc
for HMGB-1 and not HMGB-2 [16]. Surface expression
of HMGB-1 on PBMC was established by culturing cells
(37◦C, 5% CO2) directly on coverslips to allow attachment
of adherent cells overnight before stimulation with 1nM
of TSST-1. Cells were then ﬁxed and surface-stained as
above (but without the permeabilization step). Fluorescent-
labeled PBMCs were subsequently stained with Hoechst
3342 nuclear dye (molecular probes), and mounted on
slides using prolong antifade reagent (molecular probes).
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microscope equipped with a CCD camera using Northern
Eclipse software (Epix) for acquisition of images. Images
were taken with the 63x oil immersion objective lens, and
Adobe Photoshop 6.0 software was used for image layout.
2.5. Flowcytometricanalysisofsurface-expressed
HMGB-1ondifferentiatedcells
Surface-expressed HMGB-1 was analyzed by ﬂow cytometry
(FACSCalibur Flow Cytometry System, BD BioSciences
Pharmingen) using the anti-HMGB-1 antibody and sec-
ondary Alexa488-conjugated antibody described above in
conjunction with phycoerythrin (PE)-conjugated anti-CD3
and anti-CD14 antibodies (BD BioSciences Pharmingen),
with a minimum of 10000 events collected for each sample.
2.6. WesternblotanalysisofsecretedHMGB-1
PBMC or THP-1 culture supernatants were concentrated 10-
fold from original volume using Amicon Ultra centrifugal
ﬁlters with a molecular weight cut-oﬀ of 10kDa (Milli-
pore). Some culture supernatants had been further prepared
using the SDS-PAGE Clean-Up Kit (Amersham) according
to the manufacturer’s directions prior to running on a
12% polyacrylamide gel. Western blotting was performed
by semidry transfer of proteins (Trans-Blot SD Semi-Dry
Electrophoretic Transfer Cell, BioRad) onto an Immobilon-
P PVDF membrane (Millipore) which had been blocked for
1 hour at room temperature with 1% BSA, 0.5% Tween
in Tris buﬀered saline (TBS) prior to overnight incubation
(at 4◦C) with rabbit polyclonal anti-HMGB-1 antibody.
The membrane was subsequently incubated with antirabbit
IgG horse-radish-peroxidase (HRP)-conjugated secondary
antibody for 1 hour at room temperature on a shaker.
Detection of HMGB-1 was performed using super signal
substrate (Pierce) and developed as well as analyzed using
the Alpha Innotech 3400 Gel Documentation system (Alpha
Innotech, Calif, USA).
2.7. Statisticalanalysis
Statistical analysis was performed using Prism 3.0 software
package (GraphPad). The proportion of PBMCs expressing
HMGB-1 following treatment with TSST-1 or RPMI in
diﬀerent donors was compared by paired Student’s t-test.
Diﬀerences were considered signiﬁcant if P < .05.
3. RESULTS AND DISCUSSION
3.1. Secretionofcell-surfaceexpressedHMGB-1
fromdifferentiatedandadherentcells24hours
post-TSST-1stimulation
Some diﬀerentiated as well as adherent cells express HMGB-
1 on the cell surface, and this cell membrane-associated
HMGB-1 has been referred to as amphoterin to distinguish
itfromintracellularHMGB-1[17].Extracellularamphoterin
expression has been well described previously, and has been
investigated using various methods including subcellular
fractionation, immunogold electronmicroscopy, and mRNA
localizationstudies[18].Weexaminedthesurfaceexpression
of HMGB-1 (amphoterin) in human PBMC after culturing
cells over a 48-hour period in 96-well U-bottom plates in
complete growth medium. After this incubation time, we
identiﬁed a population of diﬀerentiated cells that expressed4 Mediators of Inﬂammation
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Figure 2: Nuclear translocation of HMGB-1 in human PBMC following TSST-1 stimulation. Human PBMCs were treated with either 1nM
TSST-1 or RPMI medium for 10 hours, and the intracellular expression of HMGB-1 was detected by confocal ﬂuorescent microscopy. Close-
up views from representative ﬁelds are depicted in the right panels. (a) Resting (RPMI) PBMC, intracellular HMGB-1 (green) was seen to
be localized primarily in the nucleus (blue). (b) At 10 hours following stimulation with 1nM TSST-1, HMGB-1 was seen to translocate
into the extracellular space. (c) Fluorescent microscopy image of resting T cells, and (d) TSST-1 stimulated T cells in the process of actively
translocating intracellular HMGB-1 10 hours following toxin treatment. T cells were detected by staining with antihuman CD3 antibodies
conjugatedtoAlexa594(red).(e)DetectionofHMGB-1byimmunoblotintheculturesupernatantofhumanPBMC24hoursaftertreatment
with 1nM TSST-1 or RPMI medium.
high levels of HMGB-1 in the absence of any further
treatment with exogenous stimulants (Figure 1(a)). Because
they are cells in suspension, freshly puriﬁed PBMCs do not
express amphoterin (i.e., cell-surface expressed HMGB-1).
Expression of cell-surface-associated HMGB-1 took place
over the 48-hour time course that PBMCs were cultured,
and cells of monocyte lineage had become adherent. T
cells, which were identiﬁed by costaining with anti-CD3 and
Alexa594-conjugated antimouse IgG (red), did not express
amphoterin since they remain in suspension, and the surface
expression of HMGB-1 appears to be a property of adherent
cells; however, all cells express intracellular HMGB-1 (as
showninFigure 2).Ourobservations corroboratewiththose
of Rouhiainen et al. [18], who reported the accumulation
of amphoterin in the extracellular space of cells bearing
process extensions, and HMGB-1 surface expression was
inhibited in cells without these processes. Following TSST-
1 stimulation, there was a signiﬁcant loss of amphoterin
from the cell surface from the population of cultured
adherent cells that had surface expression of HMGB-1, as
observed by ﬂuorescent microscopy (Figures 1(a) and 1(b)),
and quantiﬁed by ﬂow cytometric analysis (Figure 1(c)).S. Kalyan and A. W. Chow 5
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Figure 3: Requirement of T cells for HMGB-1 secretion following TSST-stimulation. (a) THP-1 cells or T cell-depleted human PBMCs were
stimulated with either TSST-1 (1nM), LPS (500ng/mL), or RPMI medium for 24 hours, and surface expression of HMGB-1 was examined
by ﬂuorescence microscopy. (b) The secretion of HMGB-1 in supernatants of THP-1 cells (left panel) or T cell-depleted PBMC (right panel)
24 hours following treatment with LPS, TSST-1, or RPMI medium control was examined by immunoblot. rHMGB-1 (15ng) was used as a
positive control.
Flow cytometry also conﬁrmed that the high-level surface
expression of amphoterin was conﬁned to a subpopulation
of PBMC having a high forward scatter corresponding to the
monocyte/macrophage population (estimated to be between
3% and 12% of resting PBMC among the donors tested).
More than half of these amphoterin-expressing cells released
HMGB-1 upon TSST-1 stimulation (7.3 ± 3.69% prior to
stimulation versus 3.3 ± 1.32% post- TSST-1 treatment; P
< .05, paired Student’s t-test from 4 diﬀerent donors). Flow
cytometric analysis, to our knowledge, has not been utilized
previously for quantifying the surface expression of HMGB-
1, and we found it to be a useful tool to evaluate the change
in extracellular HMGB-1 expression.
3.2. Translocationandsecretionof
intracellularHMGB-1fromhumanPBMCs
10hourspost-TSST-1stimulation
To investigate the potential change in intracellular HMGB-
1 expression upon TSST-1 exposure, human PBMCs were
treated with 1nM of TSST-1 for 10 hours, and then
subsequently evaluated for the translocation of intracellular
HMGB-1byﬂuorescencemicroscopy(Figure 2).Asreported
previously [19], HMGB-1 in resting PBMC is expected to
be localized primarily in the nucleus (Figure 2(a)). However,
10 hours after treatment with 1nM TSST-1, a signiﬁcant
proportionofPBMCshaddecreasedtheirintracellularstores
of HMGB-1 (Figure 2(b)). Previous studies that used either
LPS or the inﬂammatory cytokines IFNγ or TNFα [6, 7]a s
stimulants found that only macrophages, but not T cells,
translocated and subsequently secreted nuclear HMGB-1.
However, we found that T lymphocytes in human PBMCs
alsounderwentachangeinintracellularHMGB-1expression
following TSST-1 treatment (Figures 1(c) and 1(d)).
To verify that HMGB-1 was actively secreted from TSST-
1 treated PBMCs, we performed a Western blot analysis
of cell culture supernatants collected 24 hours post-TSST-1
treatment (Figure 2(e)).
3.3. RequirementofactivatedTcellsin
TSST-1-inducednucleartranslocationand
secretionofHMGB-1inhumanPBMC
Undiﬀerentiated and nonadherent monocytes in suspension
do not express cell-surface-associated HMGB-1. However,
during the ﬁrst steps in diﬀerentiation, monocytes actively
transport this molecule to their cell surface, and HMGB-
1 is subsequently secreted into the extracellular milieu
upon further stimulation [17]. To further investigate the
requirementofTcellsfornucleartranslocationandsecretion
of HMGB-1 following TSST-1 stimulation, we treated the
human monocytic cell line, THP-1, with either TSST-1
(1nM), LPS (500ng/mL), or leaving them untreated in
RPMImedium.THP-1cellsexpressbasallevelsofbothMHC
Class II required for TSST-1 activation and CD14 required
forLPS-inducedactivation[20].AsshowninFigure 3,TSST-
1 treatment failed to induce surface expression of HMGB-1
on undiﬀerentiated THP-1 cells, in contrast to stimulation
with LPS. We conﬁrmed this observation in primary cells
using human PBMCs that were markedly depleted of their
T cell pool that was stimulated with either TSST-1 or
LPS (Figure 3(a)). Western blot analysis also veriﬁed that
THP-1 cells and T cell-depleted PBMC secreted detectable
amounts of HMGB-1 upon LPS stimulation, but not TSST-
1t r e a t m e n t( Figure 3(b)). Collectively, these results conﬁrm
our previous studies which established that both monocytes
and T cells are required for the secretion of TNFα and IL-1β
from human PBMC stimulated with highly puriﬁed TSST-1
[13].
4. CONCLUSION
Various cell types have recently been identiﬁed as contribut-
ing to the extracellular pool of HMGB-1, including human
umbilicalveinendothelialcells[21],platelets[18],pituicytes,
and macrophages [3]. Our ﬁnding that HMGB-1 is secreted
by T cells following TSST-1 stimulation may parallel the6 Mediators of Inﬂammation
observation made by Semino et al. [22] who found that
distinct NK cell subsets secreted HMGB-1 which served to
diﬀerentiate autologous dendritic cells, and this event was
modulated by environmental stimuli. HMGB-1 was shown
to induce monocytes to diﬀerentiate into dendritic cells that
speciﬁcally polarized T cells to give a Th1 response [19],
a feature characteristic of the eﬀect of TSST-1 stimulation
on human PBMC. We previously demonstrated that the
cytokine secretion and costimulatory molecule expression
by human PBMC following TSST-1 stimulation follows a
bimodal pattern [23], with the ﬁrst phase peaking at ∼3
hours poststimulation, and a second burst at ∼24 hours
poststimulation. In light of the secretion of HMGB-1 into
the extracellular milieu at this later time point, it will be
worthwhile to determine whether the second inﬂammatory
burst and the upregulation of costimulatory molecules, such
as CD86, CD40, as well as HLA-DR (which peaked at 48
hours)[23],areindirectresponsetothesecretionofHMGB-
1 that is considered the late mediator of sepsis [24].
The best studied ligand for extracellular HMGB-1
is RAGE (receptor of advanced glycation end products)
which is upregulated on activated macrophages as well
as endothelial cells [25]. Previous studies have aimed to
determine how superantigen-activated T cells adhere to
vascular endothelial cells and induce vascular injury [26].
It was also shown that rHMGB-1 elicited proinﬂammatory
responses on endothelial cells [25]. It would, therefore, be of
interest to further investigate the role of HMGB-1 and RAGE
intheinﬂammatoryresponseandvascularendothelialinjury
mediatedbyTSST-1.ItisanticipatedthatthemodelofTSST-
1-induced inﬂammation, which necessitates the bridging of
Vβ2-speciﬁc T cells and MHC class II molecules bearing
antigen presenting cells, will provide a useful means to study
the role of HMGB-1 in T cell-monocyte interactions, Th1
polarization, and the ensuing immune response leading to
tissue injury. Finally, this study also provides a rationale to
investigate the potential to target HMGB-1 for therapy for
inﬂammatory disorders induced by TSST-1, such as toxic
shocksyndrome,asitiscurrentlybeinginvestigatedforgram
negative sepsis [9]. It should be noted that the inﬂammatory
response to diﬀerent staphylococcal exotoxins varies [27],
and it would be of clinical interest to investigate the role and
regulation of HMGB-1 in the context of other superantigens
and its potential as a primary target for superantigen-
mediated diseases.
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